Barclays, Guardant Health
In terms of valuation, Guardant Health Inc’s market capitalization stands at $6.00 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...
We recently compiled a list of the 10 Firms Kick Off Trading Week Soaring. In this article, we are going to take a look at ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating yesterday.Invest with Confidence: ...
Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...
Despite Guardant Health's positive Q4 2024 report, it remains unprofitable with negative cash flow, unlike its peer Natera.
Guardant Health Inc (GH) stock saw a modest uptick, ending the day at $45.13 which represents a slight increase of $8.47 or 23.10% from the prior close of $36.66. The stock opened at $39.04 and ...
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood ...
In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total ...
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test. On Tuesday, Guardant Health, Inc. (NASDAQ:GH) announced that ...
Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.
PALO ALTO, Calif. - Guardant Health , Inc. (NASDAQ: NASDAQ:GH), a precision oncology company with a market capitalization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback